Crossmark

Improvements of cardiac function and metabolic parameters by sodium-glucose cotransporter 2 inhibitors with no significant effects on sympathetic or parasympathetic activity in chronic heart failure

Crossref DOI link: https://doi.org/10.1007/s00380-025-02592-w

Published Online: 2025-08-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takahashi, Jinya

Fukumoto, Yoshihiro
License Information

Text and Data Mining valid from 2025-08-07

Version of Record valid from 2025-08-07
More Information

Article History

Received: 5 March 2025

Accepted: 23 July 2025

First Online: 7 August 2025

Declarations

:

: Yoshihiro Fukumoto has received research honoraria (lecture fees) from Kowa, Nippon Boehringer Ingelheim, Mitsubishi Tanabe Pharma, Ono Pharmaceutical, Daiichi Sankyo, MSD, and AstraZeneca.

Document is current

Any future updates will be listed below